(Q39636406)

13 September 2017

title

HsMAD2 mRNA expression may be a predictor of sensitivity to paclitaxel and survival in neuroblastoma (English)

1 reference

13 September 2017

1 reference

Kohei Otake

1

1 reference

13 September 2017

Keiichi Uchida

2

1 reference

13 September 2017

Kouji Tanaka

3

1 reference

13 September 2017

Yuhki Koike

4

1 reference

13 September 2017

Mikihiro Inoue

5

1 reference

13 September 2017

Kohei Matsushita

6

1 reference

13 September 2017

Motoko Ueeda

7

1 reference

13 September 2017

Kiyoshi Hashimoto

8

1 reference

13 September 2017

Takahito Kitajima

9

1 reference

13 September 2017

Yoshihiro Komada

10

1 reference

13 September 2017

Masato Kusunoki

11

1 reference

13 September 2017

language of work or name

1 reference

1 February 2011

1 reference

Pediatric Surgery International

13 September 2017

published in

1 reference

13 September 2017

volume

27

1 reference

13 September 2017

issue

2

1 reference

13 September 2017

page(s)

217-223

1 reference

https://api.crossref.org/works/10.1007%2FS00383-010-2780-5

13 September 2017

1 reference

Neuroblastoma: current drug therapy recommendations as part of the total treatment approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00383-010-2780-5

Targeting programmed cell death pathways with experimental therapeutics: opportunities in high-risk neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00383-010-2780-5

Targeted MYCN expression affects cytotoxic potential of chemotherapeutic drugs in neuroblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00383-010-2780-5

Identification of a human mitotic checkpoint gene: hsMAD2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00383-010-2780-5

On the road to cancer: aneuploidy and the mitotic checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00383-010-2780-5

Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00383-010-2780-5

Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00383-010-2780-5

Response to paclitaxel, topotecan, and topotecan-cyclophosphamide in children with untreated disseminated neuroblastoma treated in an upfront phase II investigational window: a pediatric oncology group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00383-010-2780-5

Dependence of paclitaxel sensitivity on a functional spindle assembly checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00383-010-2780-5

Mitotic checkpoint protein hsMAD2 as a marker predicting liver metastasis of human gastric cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00383-010-2780-5

Mitotic checkpoint genes, hsMAD2 and BubR1, in oesophageal squamous cancer cells and their association with 5-fluorouracil and cisplatin-based radiochemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00383-010-2780-5

Expression of short-form caspase 8 correlates with decreased sensitivity to Fas-mediated apoptosis in neuroblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00383-010-2780-5

Clinical significance of the gene expression profile in residual tumor cells after neoadjuvant chemo-radiotherapy for esophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00383-010-2780-5

Sensitivity to gemcitabine and its metabolizing enzymes in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00383-010-2780-5

Downregulation of Bim by brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from paclitaxel but not etoposide or cisplatin-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00383-010-2780-5

Role of mTOR in anticancer drug resistance: perspectives for improved drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00383-010-2780-5

Tumour response to paclitaxel in an adult with relapsed nephroblastoma

21 January 2018

1 reference

12 December 2020

Quantitative real-time reverse transcription-PCR assay for cyclin D1 expression: utility in the diagnosis of mantle cell lymphoma.

1 reference

12 December 2020

Differential susceptibility of HLA class II antigens induced by gamma-interferon in human neuroblastoma cell lines

1 reference

12 December 2020

Morphology, growth, chromosomal pattern and fibrinolytic activity of two new human neuroblastoma cell lines

1 reference

12 December 2020

Cell surface membrane antigen present on neuroblastoma cells but not fetal neuroblasts recognized by a monoclonal antibody (KP-NAC8).

1 reference

12 December 2020

New paclitaxel-cisplatin based chemotherapy regimen for advanced stage, recurrent, or refractory neuroblastoma-preliminary report

1 reference

12 December 2020

Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture

1 reference

12 December 2020

Experimental treatment of human neuroblastoma using live-attenuated poliovirus

1 reference

12 December 2020

Dramatic response of adult Wilms tumor to paclitaxel and cisplatin

1 reference

12 December 2020

10.1007/S00383-010-2780-5

Identifiers

DOI

1 reference

13 September 2017

1 reference